{
    "title": "AstraZeneca betting on blood cancer drug becoming a best-seller as it takes a \u00a32.7bn stake in biotech company Acerta Pharma",
    "url": "https://www.dailymail.co.uk/money/markets/article-3364642/AstraZeneca-betting-blood-cancer-drug-best-seller-takes-2-7bn-stake-biotech-company-Acerta-Pharma.html",
    "date": "2015-12-17",
    "keywords": [
        "company",
        "acerta",
        "executive",
        "astrazeneca",
        "cent",
        "pharma",
        "drug",
        "treatment",
        "oncology",
        "share",
        "deal",
        "soriot",
        "medicine",
        "cabinet",
        "patent",
        "protectionthe",
        "predatory",
        "bid",
        "pfizer",
        "series",
        "target",
        "plank",
        "takeover",
        "defenceyesterday",
        "ftse",
        "biotech",
        "bet",
        "blood",
        "cancer",
        "bestsellersoriot",
        "year",
        "businessastra",
        "acalabrutinib",
        "approval",
        "end",
        "option",
        "californiadeutsche",
        "bank",
        "analyst",
        "richard",
        "transaction",
        "stroke",
        "genius",
        "launch",
        "reemergence",
        "force",
        "drugmaker",
        "respiratory",
        "merger",
        "article",
        "pipeline",
        "blockbuster",
        "cholesterol",
        "crestor",
        "heartburn",
        "pill",
        "nexium",
        "protection",
        "copycatsin",
        "specialist",
        "potassium",
        "wednesday",
        "firm",
        "business",
        "yesterday"
    ],
    "category": [
        "money",
        "markets"
    ]
}